S. Stein

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

Harold J. Burstein, Anna Maria Storniolo, Sandra Franco et al. · Annals of Oncology · 2008 · 205 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Pelvic examination, tumor marker level, and gray-scale and doppler sonography in the prediction of pelvic cancer

Lynda D. Roman, Laila Muderspach, S. Stein et al. · Obstetrics and Gynecology · 1997 · 70 citations

Updated Survival Analysis of a Randomized Study of Lapatinib Alone or in Combination with Trastuzumab in Women with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab Therapy.

Kimberly Blackwell, Harold J. Burstein, George W. Sledge et al. · Cancer Research · 2009 · 44 citations

Lapatinib Alone, Lapatinib 1500, Breast Oncology +12

Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer

Beth Sherrill, Mayur M. Amonkar, S. Stein et al. · British Journal of Cancer · 2008 · 37 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Lapatinib (L) plus capecitabine (C) in HER2+ advanced breast cancer (ABC): Genomic and updated efficacy data

Charles E. Geyer, Anne Marie Martin, B. Newstat et al. · Journal of Clinical Oncology · 2007 · 32 citations

Breast Oncology, L+cvs C, Her2 Mrna Levels +19